Archived Newsletters

11. 11.29.22 -- Powering Innovation In Cell And Gene Therapy 11/29/2022

    11/29/22 Outsourced Pharma Newsletter

12. 11.28.22 -- Is Outsourcing Drug Development A Short-Term Solution Or A Long-Term Strategy? 11/28/2022

    11/28/22 Outsourced Pharma Newsletter

13. 11.28.22 -- Outsourcing History And Core Values 11/28/2022
    11/28/22 Outsourced Pharma Newsletter
14. 11.23.22 -- Using An Integrated Approach For Technology Transfers And Scale-Up 11/23/2022

    11/23/22 Outsourced Pharma Newsletter

15. 11.23.22 -- Merck, Medimmune, Keytruda: An Ultimate Outsourcing Story 11/23/2022
    11/23/22 Outsourced Pharma Newsletter
16. 11.22.22 -- Complex Injectables Development & Manufacturing: Considerations And Choosing A CDMO 11/22/2022

    11/22/22 Outsourced Pharma Newsletter

17. 11.22.22 -- Leveraging Advanced Technologies To Accelerate Pharma Development 11/22/2022

    11/22/22 Outsourced Pharma Newsletter

18. 11.21.22 -- AAV Manufacturing: Dual-Plasmid Transfection System Improves Titer & Product Quality 11/21/2022

    11/21/22 Outsourced Pharma Newsletter

19. 11.21.22 -- The "Outsourcing Master Class": 10 Modules For Success 11/21/2022
    11/21/22 Outsourced Pharma Newsletter
20. 11.18.22 -- The Future Of mAb Manufacturing 11/18/2022

    11/18/22 Outsourced Pharma Newsletter